The document outlines ProFAX's go-to-market strategy for positioning itself in the growing biopharmaceutical market. The biopharmaceutical market is large and growing, but companies are slowed down by the high computational needs of their algorithms. ProFAX aims to accelerate these algorithms using FPGA programmability to improve performance and reduce power consumption. ProFAX will create a prototype and promote its capabilities at international conferences to attract customers in need of hardware acceleration for complex biopharmaceutical modeling.

1. s

2. Outline
2
1. Biopharmaceutical market and opportunities
2. Brand positioning
3. ProFAX value added
4. Go to the market strategy

3. Biopharmaceutical market
Big growth prospects [1]:
• Global revenues of $163 billion
• Annual growth rate of more of 8%
[1] Otto, R., Santagostino, A., & Schrader, U. (2014). Rapid growth in biopharma: Challenges and
opportunities. From Sci. to Oper. Quest. Choices Strateg. Success Biopharma, 1-21.
3

4. 4
Market opportunities
• Pharmaceutical companies are shifting their R&D and sourcing focus
to biopharma.
• Increasing understanding of the interaction between drugs and the
genetic makeup of patients.
Combined with low-cost genetic profiling:
• Improvement of treatments;
• Acceleration of the outcomes of clinical trials;
• Cost of drug development reduced.

5. 5
Market issue
Companies are slowed down by the high computational needing of
the algorithms:
• high times of execution;
• high power consumption.
aims at solving this problem!

6. Brand positioning (1)
Positioning
• Acceleration of algorithms in biopharmaceutical industry by
exploiting FPGA programmability.
Promise
• A speed-up in the execution time.
• An optimization of performance over power consumption ratio.
• Our support would be crucial to enhance the productivity of such
firms.
Personas
• Their algorithms, no matter the specific field of application. As our
algorithm is provided just as an example.
6

7. Personality
• We are two students from NECST Lab at Politecnico di Milano with a
drive for computer science.
• We believe that our team, thanks to a multi-field approach, can give a
valuable contribution to bioinformatics research.
Product
• We offer hardware acceleration services in order to help companies
maximizing their performance over power consumption ratio.
Brand positioning (2)
7

8. ProFAX added value
8
• Biopharmaceutical algorithms are complex
• Close biologists collaboration & computer science experts [1]
• Modeling and statistics
The composition of our team allows for this type of successful
collaboration.
[1] Otto, R., Santagostino, A., & Schrader, U. (2014). Rapid growth in biopharma: Challenges and
opportunities. From Sci. to Oper. Quest. Choices Strateg. Success Biopharma, 1-21.
Heterogeneity of competences

9. Go to market strategy
9
1. We aim at creating a prototype to illustrate our project features
to prospect customers.
2. We will look for future customers and make them aware of
ProFAX potentialities, which have been recognized by well known
international conferences.
RAW Conference
IPDPS 2016
Chicago, IL | MAY 23-24
University Demonstration
DAC 2016
Austin, TX |JUNE 5-9

10. 10
Thanks for your attention
Lorenzo Di Tucci
Giulia Guidi
lorenzo.ditucci@mail.polimi.it
giulia.guidi@mail.polimi.it
Follow us on : https://www.facebook.com/profaxnecstlab/
Follow us on : https://twitter.com/ProFAX_NECST
Follow us on : http://www.slideshare.net/ProFAX